Onderzoeker
Ilse Hoffman
- Disciplines:Pediatrie, Gastro-enterologie, Hepatologie, Gastro-enterologie en hepatologie niet elders geclassificeerd
Affiliaties
- Vrouw en Kind (Afdeling)
Lid
Vanaf1 apr 2013 → Heden - Aangeboren Afwijkingen in Immunologie (Labo)
Lid
Vanaf1 jan 2008 → 31 dec 2011 - Departement Ontwikkeling en Regeneratie (Departement)
Lid
Vanaf1 okt 2007 → 31 dec 2007
Publicaties
21 - 30 van 106
- Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus(2021)
Auteurs: Lucas Wauters, An Outtier, Peter Bossuyt, Marc Ferrante, Ilse Hoffman, Bram Verstockt, Séverine Vermeire
- Hirschprung disease and congenital anomalies of the kidney and urinary tract (CAKUT): a genetic disorder or just a coincidence?(2020)
Auteurs: Marc Miserez, Djalila Mekahli, Ilse Hoffman
Pagina's: 126 - 129 - A survey on the impact of the COVID-19 pandemic on motility and functional investigations in Europe and considerations for recommencing activities in the early recovery phase(2020)
Auteurs: Jan Tack, Jolien Schol, Annelies Geeraerts, I-Hsuan Huang, HIDEKI MORI, Pieter Sinonquel, Esther Colomier, Hannelore Geysen, Karen Van den Houte, Wout Verbeure, et al.
- Optimisation of long-term outcomes in paediatric inflammatory bowel disease patients: role of therapeutic drug monitoring and endoscopic remission.(2020)
Auteurs: Karen van Hoeve, Séverine Vermeire, Ilse Hoffman, Ann Gils
- Optimization of serologic diagnosis of celiac disease in the pediatric setting(2020)
Auteurs: Lieve Van Hoovels, Pieter Vermeersch, Gert De Hertogh, Ilse Hoffman, Xavier Bossuyt
- Long-term outcome of immunomodulator use in pediatric patients with inflammatory bowel disease(2020)
Auteurs: Karen van Hoeve, Ilse Hoffman, Marc Ferrante, Séverine Vermeire
Pagina's: 164 - 172 - Efficacy, pharmacokinetics and immunogenicity is not affected by switching from infliximab originator to a biosimilar in pediatric patients with inflammatory bowel disease.(2019)
Auteurs: Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire
Pagina's: 317 - 324 - Adequate infliximab exposure during induction predicts remission in paediatric patients with inflammatory bowel disease(2019)
Auteurs: Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire
Pagina's: 847 - 853 - CAPNOGRAPHY IN PROCEDURAL SEDATION - A VALUE-BASED HEALTHCARE PILOT IN A HIGH-VOLUME GASTROENTEROLOGY PRACTICE(2019)
Auteurs: Raf Bisschops, Ingrid Demedts, Philip Roelandt, Christophe Dooms, Ilse Hoffman, Rachel Weissbrod, Rhodri Saunders, Gert Van Assche
Pagina's: AB426 - AB426 - SWITCHING FROM INFLIXIMAB ORIGINATOR TO A BIOSIMILAR DOES NOT AFFECT PHARMACOKINETICS, IMMUNOGENICITY AND EFFICACY IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE(2019)
Auteurs: Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Marc Ferrante, Gils Ann, Séverine Vermeire
Pagina's: S199 - S199